Document Page: First | Prev | Next | All | Image | This Release | Search

Subject: TRANSMITTAL OF POLICY MEMORANDA                                 

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: TRANSMITAL OF POLICY MEMORANDA                                                                  

Document Number:          1

Folder SEQ  #:        179






                              DEPARTMENT OF THE ARMY
                             OFFICE OF THE SURGEON GENERAL
                                    5109 LEESBURG PIKE
                                 FALLS CHURCH. VA 22041-32SS

                REPLY TO
                ATTENTION OF

          SGPS-PSP



          MEMORANDUM FOR COL ROBERT P. BELIHAR, COMMAND SURGEON, USC
                            14ACDILL AIR FORCE BASE, FL 33608-7001

          SUBJECT: Policy for Use of Anthrax Vaccine


          1. Purpose: To present recommended policy for use of ant
          vaccine.

          2. Discussion:

              a. Anthrax is a zoonotic disease caused by Bacillus
          anthracis. Man becomes infected by contact wit infected          ls
          or contaminated animal products. A biowarfare attack wit)
          solized anthrax spores would cause inhalation anthrax.

              b. An alum-precipitated preparation of purified B. ai        is
          protective antigen (PA) is an effective vaccine to si-gniy-      .y
          reduce the incidence of inhalation anthrax. Limited humai
          suggests that after the first 3 doses (0, 2, 4 weeks) of
          recommended 6-dose series, protection against inhalation i       X
          is afforded. Studies in rhesus monkeys indicate that 2 di
          14-16 days apart, provide good protection against inhalat
          anthrax. Protection is likely after two doses in humans,
          there is little information.

              C. Contraindications for use are sensitivity to form
          alum, b6nzethonium chloride and/or history of clinical an
          Reactogenicity is mild to moderate; the frequency may inc
          with successive doses. Up to 6% of recipients have exper         I
          mild discomfort at the inoculation site for up to 72 hour        @le
          a smaller proportion (




Document Page: 
First | 
Prev | 
Next | 
All | 
Image | 
This Release | 
Search






Document 6 f:/Week-36/BX003203/TRANSMITAL OF POLICY MEMORANDA/transmittal of policy memoranda:11259610133626

Control Fields 17

File Room = sep96_declassified

File Cabinet = Week-36

Box ID = BX003203

Unit = OTSG

Parent Organization = HSC

Folder Title = TRANSMITAL OF POLICY MEMORANDA

Folder Seq # = 179

Subject = TRANSMITTAL OF POLICY MEMORANDA

Document Seq # = 1

Document Date = 

Scan Date = 

Queued for Declassification = 01-JAN-1980

Short Term Referral = 01-JAN-1980

Long Term Referral = 01-JAN-1980

Permanent Referral = 01-JAN-1980

Non-Health Related Document = 01-JAN-1980

Declassified = 25-NOV-1996